跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen - TGA Drug Approval Details
Approvals
/
TGA
/
FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen
Approved
STANDARD
FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6fb3e3490618bf5f
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
6fb3e3490618bf5f
Product Name
FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen
Artg Id
313902
Artg Name
FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2019-12-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/929079369fcc3b4558bf39651d423171.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1bbed5eacc90d80da154b15032d5c1e3.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6fb3e3490618bf5f
Type
Standard
Back to TGA Approvals